Hot Features
Quoin Pharmaceuticals, Ltd., a late-stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company’s lead product is QRX003, a topical lotion, which is in phase 2 to treat netherton syndr... Quoin Pharmaceuticals, Ltd., a late-stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company’s lead product is QRX003, a topical lotion, which is in phase 2 to treat netherton syndrome (NS); phase 1 in to treat peeling skin syndrome; and in pre-clinical stage to treat SAM syndrome and ichthyosis. It also develops QRX008 for the treatment of scleroderma, which is in pre-clinical stage; and QRX009, to treat microcystic lymphatic malformations, venous malformations, angiofibroma, and other diseases. It has a research agreement with Queensland University of Technology. Quoin Pharmaceuticals, Ltd. was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. is a subsidiary of Skinvisible, Inc. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.88 | 23.4666666667 | 3.75 | 4.98 | 3.45 | 236546 | 4.37267827 | DR |
| 4 | 0.28 | 6.4367816092 | 4.35 | 5.15 | 3.25 | 712119 | 3.74667748 | DR |
| 12 | -1.36 | -22.7045075125 | 5.99 | 6.98 | 3.25 | 252482 | 3.8808759 | DR |
| 26 | -9.7 | -67.6901605024 | 14.33 | 14.49 | 3.25 | 166600 | 5.3873616 | DR |
| 52 | -3.92 | -45.8479532164 | 8.55 | 41.8 | 3.25 | 247154 | 11.63395395 | DR |
| 156 | 4.1456 | 855.821635012 | 0.4844 | 41.8 | 0.1664 | 1139610 | 1.54952081 | DR |
| 260 | -8.27 | -64.1085271318 | 12.9 | 41.8 | 0.1664 | 1213820 | 2.2020719 | DR |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.